Craniometaphyseal Dysplasia

1

Review clinical trials related to Craniometaphyseal Dysplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD)

CMD can be inherited in an autosomal dominant or recessive trait. CMD may also be caused by de novo mutations. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for CMD. The investigators also study blood samples and tissue samples from patients to learn about the processes that lead to this disorder. The investigators long-term goal is to find mechanisms to slow down bone deposition in CMD patients.

Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: UConn HealthUpdated: Apr 17, 2026Locations: 1
Eligibility criteria

CMD; unaffected individuals only if part of a participating CMD family

No CMD; unaffected individuals only as part of a participating CMD family